DrugPatentWatch Database Preview
Mayne Pharma Intl Company Profile
What is the competitive landscape for MAYNE PHARMA INTL, and what generic and branded alternatives to MAYNE PHARMA INTL drugs are available?
MAYNE PHARMA INTL has one approved drug.
Summary for Mayne Pharma Intl
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Mayne Pharma Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-001 | Jul 22, 1985 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-002 | Aug 13, 2001 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MAYNE PHARMA INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 150 mg | ➤ Subscribe | 2008-12-19 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2014-05-19 |
| ➤ Subscribe | Delayed-release Tablets | 50 mg | ➤ Subscribe | 2015-11-05 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2013-08-12 |
| ➤ Subscribe | Delayed-release Tablets | 80 mg | ➤ Subscribe | 2015-07-01 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
